Soliman, Amira http://orcid.org/0000-0002-0264-8762
Chang, Jose R.
Etminani, Kobra
Byttner, Stefan
Davidsson, Anette
Martínez-Sanchis, Begoña
Camacho, Valle
Bauckneht, Matteo
Stegeran, Roxana
Ressner, Marcus
Agudelo-Cifuentes, Marc
Chincarini, Andrea
Brendel, Matthias
Rominger, Axel
Bruffaerts, Rose
Vandenberghe, Rik
Kramberger, Milica G.
Trost, Maja
Nicastro, Nicolas
Frisoni, Giovanni B.
Lemstra, Afina W.
Berckel, Bart N. M. van
Pilotto, Andrea
Padovani, Alessandro
Morbelli, Silvia
Aarsland, Dag
Nobili, Flavio
Garibotto, Valentina
Ochoa-Figueroa, Miguel
,
Funding for this research was provided by:
VINNOVA (Grant 2017-02447)
Article History
Received: 10 November 2022
Accepted: 15 November 2022
First Online: 7 December 2022
Declarations
:
: This research study was conducted retrospectively using data obtained from European DLB (EDLB) Consortium. Local institutional ethics committee approvals for the retrospective analyses were available for all centers in Europe, including the transfer of fully anonymized imaging data. Regarding the data from Linköping’s University Hospital, informed consent was waived for this retrospective assessment and additionally, all patients were informed by letter that their medical data can be rendered anonymous and used for scientific purposes. All patients from the rest of the centers gave informed written consent for the imaging procedure and radiopharmaceutical application. The study has approval by the Swedish Ethical Review Authority (Etikprövningsmyndigheten) with approval number: 2019-00526. Part of data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012)
: Not applicable.
: The authors declare no conflicts of interest.